RecruitingNCT05129345

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for Persons Living With HIV in the Southeastern United States


Sponsor

Duke University

Enrollment

150 participants

Start Date

Jun 7, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders. Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatment goals for cardiometabolic disorders in PLWH at the study sites.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study aims to help people living with HIV in the Southeastern US better manage heart and metabolic conditions like high blood pressure, high cholesterol, and type 2 diabetes. **You may be eligible if...** - You are living with HIV and are 35 years old or older - You have one or more of: high blood pressure, high cholesterol, or type 2 diabetes - OR you are a healthcare provider, nurse, pharmacist, or community member aged 18+ involved in HIV care **You may NOT be eligible if...** - You do not understand English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Duke University - Charlotte Study Sites

Charlotte, North Carolina, United States

Duke University - Duke Study Site

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05129345


Related Trials